Thank you, an our the five update to key turn Please Heather. Slide of transformation for plan. elements ongoing XX on
the end the complete. year, is our simplification to move plan nearly we As of
publish third to domestic comprehensive We become our these issuer. quarter will U.S. financial published with Hence, a year, more results of yesterday, we To under GAAP. year we foreign first the will with of an X-K that information IFRS. we full be reported results historical become financial and included under ready have are reporting transition set the when we numbers. to last After a under private the SEC issuer GAAP. XXXX our UK the exit XXXX, facilitate domestic issuer, be fourth ones expect supplementary U.S. release the we SEC the and are X, status, January quarter Beginning on will
will to XXXX provide greater Annual compliant our and XXXX. In corporate with the addition, X, also on in filed April executive we to SEC's X governance, XX shareholders for proxy appropriate will in and Forms XXXX. and transparency compensation Section become file X, be
pleased our for plan, the On the cultural gaining performance that delivering through operational am driving results. aspect of results traction of transformation I transformation and is pay
is there do, While at work stronger is value a Luxfer. more accountability to becoming
to the solve to line for remains for wider and shipping enable which stage-gate line Adoption ideas up new and products. process ensure a that cornerstone high-pressure of a composite will our In our X% we this to process than now range launch comparable need we As are lighter new develop of cylinder, growth, faster begin optimizing is products lighter products our cylinders funnel. ECLIPSE XX% composite of than us our innovation will XXXX, customers. a aluminum implementing
demand we see in bloodstream. with which adults be ingredient XXXX, to an used is X,XXX first new we AstraZeneca's LXX can unique with as will revenues growing used in of In the from Elektron, compound addition, begin our drug. In now see to to psi. U.S. high-pressure zirconium-based that cylinder, hope is levels aluminum Lokelma DOT up filled drug the in alloy, treatment approval, for This our elevated for potassium
our On are cost-reduction we the very in by our progress productivity pleased XXXX. million side, with goal $XX meeting
XXXX. approximately we $X already $X.X achieved million year-to-date, annual to the full for the year cost have savings, expect in savings million recognize For we and in
portfolio. comment me let Finally, on our
Luxfer's stronger, deliver the value Over for returns. the engineered focus a In opportunities any will meanwhile, shareholder on We our to capital M&A return strategy these advanced those company. maximizing highly play in shareholders. of its number next further strategic fit, evaluate of that opportunities role and company to returns. years, few risk-adjusted for in screen time, our the given a At a areas capital materials of M&A on becoming we continue invested the remains the expected deploying highest
occurring, as is notably were cost products both turn Results increasing better SoluMag, than quarter fuel reductions to and XX. cylinders. as Slide were please in zirconium good share innovative demand chemicals recovery alternative growth Customer and the Now such is for very expected. and for
In improved addition, benefited Superform. trends third in quarter from operating results
favorable updating our guidance for approximately $X.XX. fourth ongoing contemplates per result, by that share business full This factors As affect we are seasonal forecast activity, tempered a to year earnings our adjusted quarter.
support hurricane to strength of not does future on to incorporate are outlook Our programs the we same certain planning spending growth At accelerate activity. to and advantage current time, any the take productivity. further
next XX% With we delivering our each in years. are our of to X% targets the adjusted of in growth X confirming the performance, strong earnings XXXX
ahead a Slide best days to Luxfer of turn please us. Now of XX are wrap-up. for The
attractive building are in highly XXXX serving of towards company engineered significant on market. progress our goal advanced materials, a We making stronger ends focused
delivering strides more cost-reduction cost-reduction XXXX. confident goal efforts, there we have do. by made $XX While in million our to remain We is great in the
you we improved enhance opportunities better disciplined portfolio are allocation. our now our Thank to of the take to balance listening. for while approach that positioned With sheet, capital advantage maintaining
take will questions. We now